ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -99.9% | 2,000 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -83.3% | 2,000 | -50.0% | 0.00% | – |
Q4 2021 | $6,000 | -25.0% | 4,000 | +20.4% | 0.00% | – |
Q3 2021 | $8,000 | -20.0% | 3,321 | +56.2% | 0.00% | – |
Q2 2021 | $10,000 | -41.2% | 2,126 | -6.5% | 0.00% | – |
Q1 2021 | $17,000 | +70.0% | 2,274 | +2.4% | 0.00% | – |
Q4 2020 | $10,000 | +25.0% | 2,221 | +4.7% | 0.00% | – |
Q3 2020 | $8,000 | +700.0% | 2,121 | +1652.9% | 0.00% | – |
Q2 2020 | $1,000 | -93.8% | 121 | -94.2% | 0.00% | – |
Q1 2020 | $16,000 | -50.0% | 2,077 | -8.1% | 0.00% | – |
Q4 2019 | $32,000 | -82.5% | 2,261 | -85.3% | 0.00% | – |
Q3 2019 | $183,000 | +110.3% | 15,427 | +150.2% | 0.00% | – |
Q2 2019 | $87,000 | +4250.0% | 6,167 | +4954.9% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 122 | +22.0% | 0.00% | – |
Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |